An ex vivo study of selenium, genistein on the morphological and nuclear changes in anticancer drug-induced apoptosis in human peripheral blood lymphocytes

BioFactors

Volumn 39, Issue 3, 2013, Pages 279-293

  Elango, Sonaa ^a,b   Subbiah, Usha ^c   Jeong, Ja In ^a  

^a Catholic University of Daegu   (South Korea)

^b SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^c UNIVERSITY OF MALAYSIA   (Malaysia)

Author keywords

Anticancer drug; Apoptosis; Cisplatin; Genistein; Lymphocytes; Mitomycin C; Selenium

Indexed keywords

CASPASE 3; CISPLATIN; GENISTEIN; MITOMYCIN; PROTEIN P53; SODIUM SELENITE;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROTECTION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG POTENTIATION; EX VIVO STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CISPLATIN; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENISTEIN; HUMANS; LYMPHOCYTES; MICROSCOPY, ELECTRON; MITOMYCIN; SELENIUM;

EID: 84879420179     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1069     Document Type: Article

References (34)

1. Lee, R., Kim, Y. J., Lee, Y. J., and Chung, H. W. (2004) The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology 195, 87-95.
2. Brozmanová, J. (2011) Selenium and cancer: from prevention to treatment. Klin Onkol 24, 171-179.
3. Brozmanová, J, Mániková, D., Vlcková, V., and Chovanec, M. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 84, 919-938.
4. Nedeljkovic, A., Radulovic, S., and Bjeldgrlic, S. (2001) Pleiotropic effect of genistein makes it a promising cancer protective compound. Arch Oncol 9, 171-174.
5. Verweij, J., den Hartigh, J., and Pinedo, H. M. (1990) In Antitumor Antibiotics. (Chabner, B. A. and Cholins, J. M., eds.). pp. 382-396, Lippincott, Philadelphia
6. Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2, 275-280.
7. Bacso, Z., Everson, R. B, and Eliason, J. F. (2000) The DNA of annexinV-binding apoptotic cells is highly fragmented. Cancer Res. 60, 4623-4628.
8. Collins, A. R, Duthie, S. J, and Dobson, V. L. (1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis. 14, 1733-1735.
9. Collins, A., Dusinska, M., Franklin, M., Somorovska, M., Petrovska, H., Duthie, S., Fillion, L., Panayiotidis, M., Raslova, K., and Vaughan, N. (1997) Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ. Mol. Mutagen. 30, 139-146.
10. Young Oh, H., Leem, J., Jung Yoon, S., Yoon, S., and Joon Hong, S. (2010) Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor. Biochem. Biophys. Res. Commun. 393, 319-324.
11. Stadtman, T. C., (1991) Biosynthesis and function of selenocysteine-containing enzymes. J. Biol. Chem. 266 (25), 16257-16260.
12. Tabassum, A., Bristow, R. G., and Venkateswaran. V. (2010) Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?. Cancer Treat Rev. 36, 230-234.
13. Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G. and Hoekstra, H. G. (1973) Selenium : biochemical role as a component of glutathione peroxidase. Science 179, 558-590.
14. Battin, E. E. and Brumaghim, J. L. (2009) Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys 55, 1-23.
15. Mukhopadhyay-Sardar, S., Rana, M. P., and Chatterjee, M. (2000) Antioxidant associated chemoprevention by selenomethionine in murine tumor model. Mol Cell Biochem., 206, 17-25.
16. Elango, N., Shila, S., and Panneerselvam, C. (2006) Enzymatic and Non enzymatic antioxidant status in stage (III)human oral squamous cell carcinoma and treated with radical radiotherapy: influence of selenium supplementation. Clin. Chim. Acta, 373: 92-98
17. Battin, E. E., and Brumaghim, J. L. (2009) Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys. 55, 1-23.
18. Peter Surai, A. C. Pappas, F. Karadas, T. T. Papazyan and V. I. Fisinin (2010) selenium enigma: health implications of an inadequate supply nutrition and health, modern dietary fat intakes in disease promotion, 379-403.
19. Brozmanová, J., Mániková, D., Vlčková, V., and Chovanec, M. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 84, 919-38.
20. Gan, L., Liu, Q., Xu, H.B., Zhu, Y.S., and Yang, X.L., (2002) Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biol. Trace Element Res. 89, 165-175.
21. Miranda, S. G., Purdie, N. G., Osborne, V. R., Coomber, B. L., and Cant, J. P. (2011) Selenomethionine increases proliferation and reduces apoptosis in bovine mammary epithelial cells under oxidative stress. J Dairy Sci. 94, 165-173.
22. Yoon, S. O, Kim, M. M., Park, S. J., Kim, D., Chung, J., and Chung, A. S. (2002) Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J, 16(1), 111-113.
23. Stefan, U. Webera, Lutz Eric Lehmanna, Jens-Christian Schewea, Jens T. Thieleb, Stefan Schr̈odera, Malte Booka, Andreas Hoefta and Frank Sẗubera (2008) Low serum α-tocopherol and selenium are associated with accelerated apoptosis in severe sepsis. BioFactors, 33, 107-119.
24. Roitt, I., Brostoff, J., and Male, D. (2001). Immunology. Mosby-Harcourt Publishers, London.
25. Fuertes, M. A., Castilla, J., Alonso, C., and Prez, J. M. (2003) Cisplatin biochemical mechanism of action: From cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med. Chem. 10, 257-266.
26. Liu, L., Yang, C., Herzog, C., Seth, R., and Kaushal, G. P. (2010) Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol. 79, 137-146.
27. Brozmanová, J., Mániková, D., Vlčková, V., and Chovanec, M. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 84, 919-938.
28. Brozmanová, J. (2011) Selenium and cancer: from prevention to treatment. Klin Onkol. 24, 171-179.
29. Battin, E. E. and Brumaghim, J. L. (2009) Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys. 55, 1-23.
30. Elango, N, Shila, S, and Panneerselvam, C (2006) Enzymatic and Non enzymatic antioxidant status in stage (III)human oral squamous cell carcinoma and treated with radical radiotherapy: Influence of selenium supplementation. Clin. Chim. Acta 373, 92-98
31. Gercel-Taylor, C., Feitelson, A. K., and Taylor, D. D. (2004) Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res. 24, 795-800.
32. Mahmood, J., Jelveh, S., Calveley, V., Zaidi, A., Doctrow, S. R., and Hill, R. P. (2011) Mitigation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol., 15
33. Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280.
34. Pirnia, F., Schneider, E., Betticher, D. C., and Borner, M. M. (2002) Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death and Differ. 9, 905-914.